Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-299319
Filing Date
2021-10-15
Accepted
2021-10-15 06:06:58
Documents
3
Period of Report
2021-10-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d195104d6k.htm 6-K 8002
2 EX-99.1 d195104dex991.htm EX-99.1 18125
3 GRAPHIC g195104ex99_1.jpg GRAPHIC 6060
  Complete submission text file 0001193125-21-299319.txt   35689
Mailing Address SUITE 802, WEST TOWER, OMNLVISION 88 SHANGKE ROAD, PUDONG DISTRICT SHANGHAI F4 201210
Business Address SUITE 802, WEST TOWER, OMNLVISION 88 SHANGKE ROAD, PUDONG DISTRICT SHANGHAI F4 201210 862160578000
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39173 | Film No.: 211324731
SIC: 2834 Pharmaceutical Preparations